Skip to main content

Table 4 Demographic differences between patients with severely low bone mass and low bone mass

From: Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism

Parameter

Severely low bone

mass(Z-score≤-2.5) n=9

Low bone mass

(Z-score>-2.5) n=51

p

Z-score of femoral neck

-2.9(-3.48,-2.68)

-1.4(-2,-0.25)

<0.01

BMD femoral neck (gm/cm2)

0.50 (0.30,0.54)

0.57 (0.50,0.68)

<0.01

Age (years)

46 (40, 66)

58 (49, 67)

0.22

Dialysis duration (months)

93.37 (69.25, 109.67)

91.97 (56.70, 130.60)

0.64

Sex (female/male)*

9/0

29/22

0.01

Hemodialysis/peritoneal dialysis*

7/2

49/2

0.04

Albumin (g/dL)

3.8 (3.15, 4.15)

3.9 (3.6, 4.10)

0.40

Intact parathyroid hormone (pg/mL)*

1527 (1074,1585)

1050 (874.60, 1380.90)

0.04

Sclerostin (pmol//L)*

3.84 (2.00, 7.60)

8.15 (5.14, 10.12)

<0.01

DKK1 (pmol//L)

24.71 (14.93, 48.14)

42.35 (25.31, 56.84)

0.09

25(OH) Vitamin D (ng/mL)*

19.05 (14.44, 27.58)

28.48 (20.60, 38.10)

0.02

Intravenous pulse calcitriol

22%

16%

0.63

Smoking

0%

2%

0.67

Diabetes mellitus

11%

18%

0.63

Hypertension

67%

65%

0.91

Lipid lower agents

0%

12%

0.28

  1. DKK1 Dickkopf-related protein 1, BMD Bone mineral density
  2. median (interquartile range)
  3. *p<0.05